Financials

  • Market Capitalization 351.79 M
  • Employee 533
  • Founded 2002
  • CEO N/A
  • Website www.vandapharma.com
  • Headquarter Delaware, United States
  • FIGI BBG000HT5MG6
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.7
Rapporto prezzo/fatturato
1.88

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3188
PRLD
Prelude Therapeutics Incorporated - Common Stock
4.50 USD+2.51%-10.89%+2.97%+455.56%358.40 M USD
3199
PALI
Palisade Bio, Inc. - Common Stock
2.04 USD+5.70%+3.03%+21.43%+20.00%354.10 M USD
3221
HELP
Cybin Inc. - Common Stock
6.66 USD-0.30%+11.74%+56.34%-25.75%343.87 M USD
3228
FATE
Fate Therapeutics, Inc. - Common Stock
2.92 USD-2.34%+0.34%+43.84%+156.14%340.35 M USD

Notizie